ВведениеОдной из основных причин летальности у постра давших в критическом состоянии, перенесших шок и кро вопотерю, являются инфекционные осложнения [1][2][3][4]. IntroductionInfection complications are one of the main causes of mortality in critically ill patients after shock and blood loss [1][2][3][4]. The common infectious agent is the opportunistic Objective: to estimate the clinical and prognostic value of the blood levels of lipopolysaharide binding protein (LPS BP) and lac tate in critically ill polytrauma patients. Subjects and methods. An analysis was made of the results of an examination in critical ly ill polytrauma victims who were retrospectively classified in accordance with the 1992 ACCP/SCCM criteria: systemic inflam matory response syndrome (n=18), local infection (n=36), sepsis (n=27), severe sepsis (n=12), and septic shock (n=6). A case was regarded as infection when the source of the latter was established and it was microbiologically verified. The investigators determined serum LPS BP levels by an immunochemiluminescence analyzer (IMMULITE ONE, USA) and venous whole blood lactate concentrations by a Roche Omni S analyzer (Germany). Results. The development of infectious complications was noted in 81% of the polytrauma patients by days 5-7; by days 8-10, 45% were diagnosed as having sepsis whose severe course was characterized by the addition of polyresistant gram negative microorganisms. An early increase in the concentration and fre quency of diagnostic levels of serum LPS BP was ascertained in the polytrauma patients before infection was microbiologically verified. There was a strong direct correlation between lactate and LPS BP levels. Conclusion. The findings suggest that LPS BP and lactate are of diagnostic and prognostic value and may be used as early markers of pyoseptic complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.